Skip to content

A clinical study to investigate the antibacterial efficacy of arbutin metabolites in urine.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519011-34-00
Acronym
SB-CYS 0124
Enrollment
14
Registered
2025-07-14
Start date
2025-08-04
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infection

Interventions

None listed

Sponsors

Schaper & Bruemmer GmbH & Co. KG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026